Mangalam Drugs And Organics Limited has informed the Exchange about Fraud/Default/Arrest

Regulatory & Legal View source PDF Explain this filing

MANGALAM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+1.0%Reaction day

₹61.00

prior close

₹60.59

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.8%+1.8% vs market

Pharmaceuticals peers, median of 157sector-0.9%+1.9% vs sector

On the reaction day the stock moved 1.8 pts more than Nifty Microcap 250 and 1.9 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+1.7

10m

+0.0

15m

+0.1

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+1.0-0.8+1.8-0.9+1.9

Next day

-10.8-1.0-9.9-1.4-9.4

-20.6-1.3-19.3-1.5-19.1

-23.5-2.8-20.7-1.8-21.7

-34.8-3.4-31.4-3.3-31.5

-40.5-3.3-37.2-2.8-37.7

-51.8-2.4-49.4-2.5-49.3

15d

-59.1-5.8-53.3-4.2-54.9

-59.8-7.0-52.9-5.2-54.6

-19.1-9.8-9.3-6.6-12.5

-47.3-7.1-40.2-10.1-37.2

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 157Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Mangalam Drugs And Organics Limited has submitted a disclosure to NSE under the 'Fraud / Default / Arrest' reporting category. The headline alone does not specify whether this relates to an internal fraud, a loan default, or an arrest of a promoter or employee. No further details, financial figures, or party names were provided in the available filing text. Investors should refer to the full filing or the company's detailed submission for specifics on the nature and scale of the event.

Likely market impact

Without details on the nature, quantum, or parties involved, the stock could see short-term volatility or negative sentiment. Shareholders should await the full filing and watch for any follow-up clarifications from the company or exchange.